» Articles » PMID: 35757989

Mechanisms of Cell Injury Induced by Inhaled Molybdenum Trioxide Nanoparticles in Golden Syrian Hamsters

Overview
Specialty Biology
Date 2022 Jun 27
PMID 35757989
Authors
Affiliations
Soon will be listed here.
Abstract

Molybdenum trioxide nanoparticles (MoO NPs) are extensively used in the biomedical, agricultural, and engineering fields that may increase exposure and adverse health effects to the human population. The purpose of this study is to evaluate a possible molecular mechanism leading to cell damage and death following pulmonary exposure to inhaled MoO NPs. Animals were separated into four groups: two control groups exposed to room air or aerosolized water and two treated groups exposed to aerosolized MoO NPs with a concentration of 5 mg/m NPs (4 h/day for eight days) and given a one-day (T-1) or seven-day (T-7) recovery period post exposure. Pulmonary toxicity was evaluated with total and differential cell counts. Increases were seen in total cell numbers, neutrophils, and multinucleated macrophages in the T-1 group, with increases in lymphocytes in the T-7 group (* < 0.05). To evaluate the mechanism of toxicity, protein levels of Beclin-1, light chain 3 (LC3)-I/II, P-62, cathepsin B, NLRP3, ASC, caspase-1, interleukin (IL)-1β, and tumor necrosis factor-α (TNF-α) were assessed in lung tissue. Immunoblot analyses indicated 1.4- and 1.8-fold increases in Beclin-1 in treated groups (T-1 and T-7, respectively, * < 0.05), but no change in protein levels of LC3-I/II in either treated group. The levels of cathepsin B were 2.8- and 2.3-fold higher in treated lungs (T-1 and T-7, respectively, * < 0.05), the levels of NLRP3 had a fold increase of 2.5 and 3.6 (T-1 * < 0.05, T-7 ** < 0.01, respectively), and the levels of caspase-1 indicated a 3.8- and 3.0-fold increase in treated lungs (T-1 and T-7, respectively, * < 0.05). Morphological changes were studied using light and electron microscopy showing alterations to airway epithelium and the alveoli, along with particle internalization in macrophages. The results from this study may indicate that inhalation exposure to MoO NPs may interrupt the autophagic flux and induce cytotoxicity and lung injury through pyroptosis cell death and activation of caspase-1.

Citing Articles

Nanomaterial-induced pyroptosis: a cell type-specific perspective.

Wang Z, Wang M, Zeng X, Yue X, Wei P Front Cell Dev Biol. 2024; 11:1322305.

PMID: 38264354 PMC: 10803419. DOI: 10.3389/fcell.2023.1322305.


Distribution of molybdenum in soft tissues and blood of rats after intratracheal instillation of molybdenum(IV) sulfide nano- and microparticles.

Kuras R, Stepnik M, Grobelny J, Tomaszewska E, Stanislawska M, Domeradzka-Gajda K Toxicol Res. 2024; 40(1):163-177.

PMID: 38223673 PMC: 10786813. DOI: 10.1007/s43188-023-00213-0.


The therapeutic bionanoscience interface.

Melendez J Exp Biol Med (Maywood). 2022; 247(23):2065-2066.

PMID: 36533612 PMC: 9837299. DOI: 10.1177/15353702221144090.

References
1.
Wang X, Sun B, Liu S, Xia T . Structure Activity Relationships of Engineered Nanomaterials in inducing NLRP3 Inflammasome Activation and Chronic Lung Fibrosis. NanoImpact. 2017; 6:99-108. PMC: 5415341. DOI: 10.1016/j.impact.2016.08.002. View

2.
Odularu A, Ajibade P, Mbese J . Impact of Molybdenum Compounds as Anticancer Agents. Bioinorg Chem Appl. 2019; 2019:6416198. PMC: 6754869. DOI: 10.1155/2019/6416198. View

3.
Mourdikoudis S, Pallares R, Thanh N . Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018; 10(27):12871-12934. DOI: 10.1039/c8nr02278j. View

4.
Bonner J . Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc. 2010; 7(2):138-41. PMC: 3266021. DOI: 10.1513/pats.200907-061RM. View

5.
Srinivas A, Rao P, Selvam G, Murthy P, Reddy P . Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett. 2011; 205(2):105-15. DOI: 10.1016/j.toxlet.2011.05.1027. View